国产竞品围攻+原料供应紧张 赛诺菲一款降脂药上市仅5年就宣布退出中国市场

每日经济新闻
Aug 05

近日,市场上流传一份由赛诺菲发布、题为“关于波立达(阿利西尤单抗注射液)的告知函”的文件,落款时间为2025年7月1日。其中提到,赛诺菲决定停止波立达在中国市场的推广。  波立达曾被赛诺菲视作“心血管领域革命性新药”的降脂产品,在中国获批仅五年。8月4日,赛诺菲方面向《每日经济新闻》记者证实,赛诺菲停止波立达在中国市场的供应,停供主要是由于全球供应问题,以及公司心血管市场策略和管线优化。  波立达...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10